Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123296
Filing Date
2024-11-07
Accepted
2024-11-07 16:06:56
Documents
114
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20240930.htm   iXBRL 10-Q 3407023
2 EX-10.1 mnkd-ex10_1.htm EX-10.1 66271
3 EX-10.2 mnkd-ex10_2.htm EX-10.2 13750
4 EX-10.3 mnkd-ex10_3.htm EX-10.3 121172
5 EX-31.1 mnkd-ex31_1.htm EX-31.1 14428
6 EX-31.2 mnkd-ex31_2.htm EX-31.2 14427
7 EX-32.1 mnkd-ex32_1.htm EX-32.1 9886
8 EX-32.2 mnkd-ex32_2.htm EX-32.2 9898
  Complete submission text file 0000950170-24-123296.txt   16208986

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240930.xsd EX-101.SCH 2513154
117 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240930_htm.xml XML 2978652
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 241435591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)